难治性癌痛应用硬膜外自控镇痛治疗的观察与分析  

作　　者：刘发有 

机构地区：[1]甘肃省高台县人民医院,甘肃高台734300

出　　处：《医学信息（中旬刊）》2011年第1期26-27,共2页Medical Information Operations Sciences Fascicule

摘　　要：目的:探索难治性癌痛的院外有效治疗方法。方法:124例难治性癌痛的患者,按治疗途径不同随机分为:观察组(硬膜外自控镇痛组n=62),对照组(肌肉注射组n=62),对比分析两组难治性癌痛的治疗效果及安全性。结果:104例病人按照预先设计要求完成,其中观察组52例,对照组52例。观察组在癌痛缓解方面:疼痛范围、疼痛性质、疼痛强度与对照组比较差异有显著性(P<0.01),终未生存期生活质量比较差异有显著性(P<0.01),对照组发生意外死亡占7.69%。结论:应用硬膜外自控镇痛院外治疗难治性癌痛效果好,安全性高,操作简单,易于推广。Objective：To explore the effective refractory cancer pain treatment. Methods： 124 patients with refractory cancer pain patients, according to treatment for different randomly divided into two groups and the control group. Observation group （ epidural analgesia group n = 62 ）, the control group （ intramuscular group n = 62）. Compared two groups of refractory cancer pain treatment and safety. Results ：104 patients completed the patient in accordance with the pre - design requirements, ineluding observation of 5：2 eases ,52 cases of the control group. The observation group of cancer pain relief：the pain range ,the nature of pain, pain intensity compared with control group the difference was statistically significant （ P 〈 0.01 ） ,were ultimately unable to survive on the quality of life difference was significant （ P 〈 0.01 ）, the control group occurred accounted for 7.69% of accidental deaths. Conclusion：Controlled epidural analgesia for refractory cancer pain at home, effective, safe, simple. easy to spread.

关 键 词：难治性癌痛 硬膜外间隙 自控镇痛 

分 类 号：R614.42[医药卫生—麻醉学]